5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $297M (100.0% shares, 0.0% debt)

Holdings (10)

— AKOUOS INC 27.6%

Value $82.01M Shares 4,135,784 Est. Cost $22.50 Unrealized —

— HOMOLOGY MEDICINES INC 17.2%

Value $51.21M Shares 4,535,919 Est. Cost $20.70 Unrealized —

ARVN ARVINAS INC 14.3%

Value $42.47M Shares 500,000 Est. Cost $29.28 Unrealized +17.8%

CABA CABALETTA BIO INC 14.2%

Value $42.07M Shares 3,371,263 Est. Cost $11.85 Unrealized +9.5%

IDYA IDEAYA BIOSCIENCES INC 8.5%

Value $25.17M Shares 1,798,066 Est. Cost $7.13 Unrealized +89.9%

— SCPHARMACEUTICALS INC 6.8%

Value $20.27M Shares 3,831,474 Est. Cost $5.92 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 6.5%

Value $19.22M Shares 1,362,286 Est. Cost $19.04 Unrealized -26.8%

— APREA THERAPEUTICS INC 2.3%

Value $6.778M Shares 1,377,654 Est. Cost $45.89 Unrealized —

— CIDARA THERAPEUTICS INC 1.4%

Value $4.013M Shares 2,006,511 Est. Cost $3.84 Unrealized —

— 5 01 ACQUISITION CORP 1.3%

Value $3.713M Shares 365,126 Est. Cost $10.17 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AKOUOS INC	4,135,784	$82.01M	27.6%	$22.50	—	COM	00973J101
—	HOMOLOGY MEDICINES INC	4,535,919	$51.21M	17.2%	$20.70	—	COM	438083107
ARVN	ARVINAS INC	500,000	$42.47M	14.3%	$29.28	+17.8%	COM	04335A105
CABA	CABALETTA BIO INC	3,371,263	$42.07M	14.2%	$11.85	+9.5%	COM	12674W109
IDYA	IDEAYA BIOSCIENCES INC	1,798,066	$25.17M	8.5%	$7.13	+89.9%	COM	45166A102
—	SCPHARMACEUTICALS INC	3,831,474	$20.27M	6.8%	$5.92	—	COM	810648105
CRNX	CRINETICS PHARMACEUTICALS IN	1,362,286	$19.22M	6.5%	$19.04	-26.8%	COM	22663K107
—	APREA THERAPEUTICS INC	1,377,654	$6.778M	2.3%	$45.89	—	COM	03836J102
—	CIDARA THERAPEUTICS INC	2,006,511	$4.013M	1.4%	$3.84	—	COM	171757107
—	5 01 ACQUISITION CORP	365,126	$3.713M	1.3%	$10.17	—	COM CL A	33836P105